| Target Group |
- Medical staff of related specialties including Infectious Disease, Clinical Microbiology, Intensive Care Unit, Pathology, Paediatrics, Medicine, A&E, Public Health, Community Medicine and Family Medicine and other physicians who are interested in the subjects
- Infection control nurses and other healthcare professionals who are involved in infection control
- Health care professionals in HA, DH and private sectors |
| Speakers |
|
Session I MDRO and COVID-19
|
| Time |
Topic |
Speaker |
Video |
| 09:00 – 09:05 |
Welcome address |
Dr Hong CHEN
Consultant i/c, HA IDCTC / Head ICB CHP |
|
| 09:05 – 09:50 |
MDRO outbreaks and control during the COVID-19 pandemic |
Prof Dale FISHER
Senior Consultant, Division of Infectious Diseases, National University Hospital, Singapore/ Chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore |
 |
| 09:50 – 10:35 |
COVID-19 US Impact |
Dr Fernanda LESSA
Program Chief, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, USA |
|
| 10:35 – 10:50 |
Discussion Session |
|
|
| 10:50 – 11:00 |
Break |
|
|
| 11:00 – 11:45 |
AMR in China |
Prof George Fu GAO
Director at the CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, China/ Member of the Chinese Academy of Sciences, China/ International member of the U.S. National Academy of Sciences/ Foreign member of the U.K. Royal Society / Member of the German National Academy of Sciences Leopoldina/ Senior Fellow of Hong Kong Institute for Advanced Study, City University of Hong Kong |
|
| 11:45 – 12:30 |
Epidemiology of Multi-Drug Resistant Organisms before and during COVID-19 in Hong Kong |
Dr Vincent CHENG
Chief of Service, Department of Microbiology/ Consultant Microbiologist / Infection Control Officer, QMH
Ms Shuk Ching WONG
Honorary Associate Professor, School of Nursing, The University of Hong Kong / Honorary Associate Professor, Department of Microbiology, School of Clinical Medicine, The University of Hong Kong/
Senior Nursing Officer, Infection Control Team, QMH
|
|
| 12:30 – 12:45 |
Discussion Session |
|
|
| 12:45 – 14:00 |
Lunch |
|
|
|
Session II Update on management of MDRO
|
| Time |
Topic |
Speaker |
Video |
| 14:00 – 14:45 |
The challenge of preventing pathogen spread in hospitals, including MDRO and SARS-CoV-2 |
Prof. Hugo SAX
Research Fellow, Department Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerlan |
|
| 14:45 – 15:30 |
Update on Decolonization for MDRO Containment & Infection Prevention |
Prof Susan HUANG
Professor of Medicine, Division of Infectious Diseases and Health Policy / Research Institute, University of California Irvine School of Medicine, USA |
|
| 15:30 – 15:45 |
Discussion Session |
|
|
| 15:45 – 16:00 |
Break |
|
|
| 16:00 – 16:45 |
101 of Multi-drug Resistant Organisms in Hospital |
Dr Teresa WANG
Specialist in Clinical Microbiology and Infection, Hong Kong Medical Consultants/ Honorary Assistant Professor, Hong Kong Children's Hospital Locum Specialist(Path)/ Honorary Assistant Professor, Department of Microbiology, The University of Hong Kong/ Honorary Clinical Assistant Professor, Department of Microbiology, The Chinese University of Hong Kong
|
|
| 16:45 – 17:30 |
Microbiome Modulation in Combating MDRO during COVID Pandemic |
Prof. Siew C. NG
Assistant Dean (Development)/ Director, Microbiota I-Center (MagIC) /Professor, Department of Medicine & Therapeutics/Faculty of Medicine, The Chinese University of Hong Kong/ Honorary Consultant, Prince of Wales Hospital, Hospital Authority |
|
| 17:30 – 17:45 |
Discussion Session |
|
|
|
25°C
32°C
30.4°C
Top